Xeris Biopharma Holdings Inc (XERS)
EBITDA Margin
-22.74%
Quarterly · Period ending:
XERS EBITDA Margin
Latest reported-22.74%period ending
Latest reported-22.74%period ending
XERS Quarterly EBITDA Margin (-1302.54% → -22.74%)
Quarterly ebitda margin
High-resolution chart · PNG
XERS ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -22.7405% | |
| 14.8303% | |
| 16.4637% | |
| 14.8938% | |
| 12.013% | |
| 2.0426% | |
| 9.5226% | |
| -15.0217% | |
| -6.5287% | |
| -20.7367% | |
| -7.5445% | |
| -4.8075% | |
| -27.9573% | |
| -22.4033% | |
| -16.2865% | |
| -50.8326% | |
| -79.088% | |
| -124.8992% | |
| -221.953% | |
| -216.4749% | |
| -285.201% | |
| -198.6943% | |
| -234.5231% | |
| -140.6541% | |
| -1,068.0316% | |
| -1,530.481% | |
| -1,696.8348% | |
| -8,975.2322% | |
| -10,343.125% | |
| -9,709.6774% | |
| -2,395.7553% | |
| -2,409.7938% | |
| -1,507.5702% | |
| -4,430.7985% | |
| -1,946.6809% | |
| -4,423.5294% | |
| -914.3363% | |
| -1,302.5424% |